MetLife, Inc. (NYSE:MET) Earns “Buy” Rating from Langen Mcalenn

Langen Mcalenn reissued their buy rating on shares of MetLife, Inc. (NYSE:MET) in a research note released on Wednesday, August 16th. Langen Mcalenn also issued estimates for MetLife’s Q3 2017 earnings at $1.09 EPS, Q4 2017 earnings at $1.09 EPS, FY2017 earnings at $4.40 EPS, Q1 2018 earnings at $1.15 EPS, Q2 2018 earnings at $1.14 EPS, Q3 2018 earnings at $1.23 EPS, Q4 2018 earnings at $1.24 EPS and FY2018 earnings at $4.75 EPS.

MET has been the topic of a number of other reports. Citigroup Inc. set a $51.00 price objective on shares of MetLife and gave the company a sell rating in a research note on Friday, July 7th. Royal Bank Of Canada reissued a buy rating and issued a $62.00 price objective on shares of MetLife in a research note on Wednesday, July 12th. Wells Fargo & Company reissued an outperform rating and issued a $63.00 price objective (up from $61.00) on shares of MetLife in a research note on Wednesday, July 12th. Keefe, Bruyette & Woods reissued a buy rating and issued a $59.00 price objective on shares of MetLife in a research note on Thursday, August 3rd. Finally, TheStreet raised shares of MetLife from a c rating to a b- rating in a research note on Monday, July 24th. Two investment analysts have rated the stock with a sell rating, six have given a hold rating and ten have assigned a buy rating to the company’s stock. MetLife has a consensus rating of Hold and a consensus target price of $58.38.

Shares of MetLife (MET) traded down 1.03% during trading on Wednesday, reaching $47.31. The company had a trading volume of 9,368,908 shares. MetLife has a 12 month low of $38.19 and a 12 month high of $52.07. The company has a market cap of $50.28 billion, a price-to-earnings ratio of 556.59 and a beta of 1.44. The firm has a 50 day moving average price of $48.11 and a 200 day moving average price of $47.27.

MetLife (NYSE:MET) last announced its earnings results on Wednesday, August 2nd. The financial services provider reported $1.30 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.28 by $0.02. MetLife had a net margin of 0.30% and a return on equity of 8.51%. The company had revenue of $17.39 billion for the quarter, compared to analysts’ expectations of $17.11 billion. During the same period last year, the firm earned $0.83 earnings per share. The business’s revenue for the quarter was up 2.5% on a year-over-year basis. Analysts predict that MetLife will post $4.86 earnings per share for the current year.

TRADEMARK VIOLATION NOTICE: “MetLife, Inc. (NYSE:MET) Earns “Buy” Rating from Langen Mcalenn” was originally published by BNB Daily and is the property of of BNB Daily. If you are viewing this report on another site, it was stolen and republished in violation of U.S. & international copyright & trademark law. The original version of this report can be read at https://www.baseball-news-blog.com/2017/09/05/langen-mcalenn-reiterates-buy-rating-for-metlife-inc-met-updated.html.

The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 13th. Shareholders of record on Monday, August 7th will be issued a $0.40 dividend. This represents a $1.60 dividend on an annualized basis and a yield of 3.38%. The ex-dividend date is Thursday, August 3rd. MetLife’s dividend payout ratio (DPR) is presently 1,777.98%.

Institutional investors have recently made changes to their positions in the business. First National Bank of Omaha purchased a new stake in shares of MetLife in the 1st quarter worth about $206,000. Wealth Enhancement Advisory Services LLC purchased a new stake in shares of MetLife in the 1st quarter worth about $786,000. First United Bank Trust lifted its position in shares of MetLife by 5.8% in the 1st quarter. First United Bank Trust now owns 28,693 shares of the financial services provider’s stock worth $1,515,000 after purchasing an additional 1,570 shares during the period. Harvey Capital Management Inc. lifted its position in shares of MetLife by 1,059.3% in the 1st quarter. Harvey Capital Management Inc. now owns 62,600 shares of the financial services provider’s stock worth $3,306,000 after purchasing an additional 57,200 shares during the period. Finally, Reliance Trust Co. of Delaware lifted its position in shares of MetLife by 2.4% in the 1st quarter. Reliance Trust Co. of Delaware now owns 40,694 shares of the financial services provider’s stock worth $2,149,000 after purchasing an additional 942 shares during the period. 74.24% of the stock is currently owned by institutional investors and hedge funds.

MetLife Company Profile

MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses.

Analyst Recommendations for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply